Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group

PURPOSE: Five-year overall survival (OS) for children with B-cell precursor acute lymphoblastic leukemia (B-ALL) exceeds 90% with risk-adapted therapy. Age, initial WBC count, genetic aberrations, and minimal residual disease (MRD) are used for risk stratification. Intrachromosomal amplification of...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Heerema, Nyla A., Carroll, Andrew J., Devidas, Meenakshi, Loh, Mignon L., Borowitz, Michael J., Gastier-Foster, Julie M., Larsen, Eric C., Mattano, Leonard A., Maloney, Kelly W., Willman, Cheryl L., Wood, Brent L., Winick, Naomi J., Carroll, William L., Hunger, Stephen P., Raetz, Elizabeth A.
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society of Clinical Oncology 2013
الموضوعات:
ORIGINAL REPORTS
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3770866/
https://ncbi.nlm.nih.gov/pubmed/23940221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.49.1308
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة